These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15888463)

  • 1. In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative.
    Dabur R; Chhillar AK; Yadav V; Kamal PK; Gupta J; Sharma GL
    J Med Microbiol; 2005 Jun; 54(Pt 6):549-552. PubMed ID: 15888463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel antifungal pyrrole derivative from Datura metel leaves.
    Dabur R; Ali M; Singh H; Gupta J; Sharma GL
    Pharmazie; 2004 Jul; 59(7):568-70. PubMed ID: 15296098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antifungal effects of the antifungal compound 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate on Aspergillus fumigatus.
    Dabur R; Mandal TK; Sharma GL
    J Med Microbiol; 2007 Jun; 56(Pt 6):815-818. PubMed ID: 17510268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis.
    Dabur R; Diwedi SK; Yadav V; Mishra V; Singh R; Singh H; Sharma GL
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4365-7. PubMed ID: 16189123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on antimycotic properties of Datura metel.
    Rajesh ; Sharma GL
    J Ethnopharmacol; 2002 May; 80(2-3):193-7. PubMed ID: 12007710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.
    Jana GH; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3592-5. PubMed ID: 15978808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal agents, II: Synthesis and antifungal activities of aryl-1H-pyrrol-2-yl-1H-imidazol-1-yl-methane derivatives with unsaturated chains.
    Massa S; Ragno R; Porretta GC; Mai A; Retico A; Artico M; Simonetti N
    Arch Pharm (Weinheim); 1993 Sep; 326(9):539-46. PubMed ID: 8239946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antifungal activity of substituted-10-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indoles.
    Tiwari RK; Verma AK; Chhillar AK; Singh D; Singh J; Kasi Sankar V; Yadav V; Sharma GL; Chandra R
    Bioorg Med Chem; 2006 Apr; 14(8):2747-52. PubMed ID: 16377197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal potential of Indian medicinal plants.
    Dabur R; Singh H; Chhillar AK; Ali M; Sharma GL
    Fitoterapia; 2004 Jun; 75(3-4):389-91. PubMed ID: 15159003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
    J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.
    Sakko M; Moore C; Novak-Frazer L; Rautemaa V; Sorsa T; Hietala P; Järvinen A; Bowyer P; Tjäderhane L; Rautemaa R
    Mycoses; 2014 Apr; 57(4):214-21. PubMed ID: 24125484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients.
    Nasri E; Fakhim H; Vaezi A; Khalilzadeh S; Ahangarkani F; Laal Kargar M; Abtahian Z; Badali H
    Mycoses; 2019 May; 62(5):434-440. PubMed ID: 30681747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
    Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
    J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel indazole-linked triazoles as antifungal agents.
    Park JS; Yu KA; Kang TH; Kim S; Suh YG
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3486-90. PubMed ID: 17433670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.